Associated Papers
Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy.
Schuldt M et al.
Cells, 2021
34831173 (PubMed )
Supplement: cells-10-02950-s001.zip › cells-1315660-supplementary.pdf
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy.
Schuldt M et al.
Circulation. Heart Failure, 2021
33430602 (PubMed )
Supplement: hhf-14-e007022-s001.pdf
Select a paper to view details